Infection-associated vasculitides
Corresponding Author
Syed A. Haq
BSM Medical University, Dhaka, Bangladesh
Correspondence: Syed A. Haq, Professor of Rheumatology, BSM Medical University, Dhaka, Bangladesh. Email: [email protected]Search for more papers by this authorChristian Pagnoux
Vasculitis Clinic, Mount Sinai Hospital, Toronto, Ontario, Canada
Search for more papers by this authorCorresponding Author
Syed A. Haq
BSM Medical University, Dhaka, Bangladesh
Correspondence: Syed A. Haq, Professor of Rheumatology, BSM Medical University, Dhaka, Bangladesh. Email: [email protected]Search for more papers by this authorChristian Pagnoux
Vasculitis Clinic, Mount Sinai Hospital, Toronto, Ontario, Canada
Search for more papers by this authorAbstract
Vasculitides are disorders characterized by inflammation of the vessel walls, often caused by autoimmunity, but sometimes as a result of microbial invasion. Almost all types of microbes including bacteria, viruses, protozoa and fungi have been incriminated in the pathogenesis of vasculitis. Accurate etiological diagnosis is important since immunosuppressive treatment may lead to further deterioration if infection is the cause of vasculitis. Clinical features sometimes provide clues to the etiology. Further evaluation requires a focused and cost-effective plan of laboratory investigation. The investigations aim at establishing the diagnosis of vasculitis and identify the causative organism. An accurate diagnosis of vasculitis optimally requires histological examination and imaging. For infection-associated vasculitis, the identification of the organism requires studies of stained specimens, cultures, and/or detection of antigens and antibodies. Ideally, the treatment involves administration of an appropriate antimicrobial. In non-self-limiting types of vasculitides, glucocorticoids are needed when the symptoms are progressive, with vital organs involvement, and sometimes, when there is no antimicrobial agent of proven efficacy against the incriminated agent. Additional immunosuppressive agents or interventions must be considered when the disease is severe and/or post-infective immune mechanisms are involved in the pathogenesis, e.g., severe HBV- or HCV-associated vasculitides. Available preventative vaccinations are also crucial. The incidence of HBV-associated vasculitides dramatically decreased following HBV vaccination campaigns, and other infection-associated vasculitides may as well in the future.
Disclaimers/conflict of interest
None.
References
- 1Jennette JC, Falk RJ, Bacon PA et al. (2013) 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65, 1–11.
- 2Roane DW, Griger DR (1999) An approach to diagnosis and initial management of systemic vasculitis. Am Fam Physician 60, 1421.
- 3Terrier B, Cacoub P (2013) Renal involvement in HCV-related vasculitis. Clin Res Hepatol Gastroenterol 37, 334–9.
- 4Karakayali B, Yilma S, Çakir D, Günes PG, Güven S, Islek S (2017) Henoch-Schonlein purpura associated with primary active Epstein–Barr virus infection: a case report. Pan Afr Med J 27, 1–4.
- 5Singh H, Tanwar VS, Sukhija G, Kaur P, Govil K (2016) Vasculitis as a presenting manifestation of chronic hepatitis B virus infection: a case report. J Clin Diagn Res 10 (2), OD25–6.
- 6Joshi U, Subedi R, Gajurel BP (2017) Hepatitis B virus induced cytoplasmic antineutrophil cytoplasmic antibody-mediated vasculitis causing subarachnoid hemorrhage, acute transverse myelitis, and nephropathy: a case report. J Med Case Rep 11, 91.
- 7Kaeley N, Kamakshi N (2016) Eosinophilic granulomatosis with polyangiitis (EGPA) and hepatitis B infection – a rare association. J Clin Diagn Res 10, OD07–9.
- 8Hausler MG, Ramaekers VT, Reul J, Meilicke R, Heimann G (1998) Early and late onset manifestations of cerebral vasculitis related to varicella zoster. Neuropediatrics 29, 202–7.
- 9Gilden D, White T, Boyer PJ et al. (2016) Varicella zoster virus infection in granulomatous arteritis of the aorta. J Infect Dis 213, 1866–71.
- 10Gilden D, Nagel MA (2016) Varicella zoster virus and giant cell arteritis. Curr Opin Infect Dis 29, 275–9.
- 11Gözüküçük M, Gürsoy AY, Kankaya D, Atabekoglu C (2016) Single-organ vasculitis of the cervix accompanying human papillomavirus infection. Interv Med Appl Sci 8, 93–5.
- 12Mine I, Taguchi M, Sakurai Y, Takeuchi M (2017) Bilateral idiopathic retinal vasculitis following coxsackievirus A4 infection: a case report. BMC Ophthalmol 17, 128–32.
- 13Lahoti AM, Taori AK, Dhok AP, Rawat JS, Chandak NU (2017) Intracranial aneurysms involving circle of willis in a child with human immunodeficiency virus associated vasculitis – a rare case report. J Clin Diagn Res 11, TD13–5.
- 14Cojocariu C, Stanciu C, Ancuta C, Danciu M, Chiriac S, Trifan A (2016) Immunoglobulin A vasculitis complicated with Clostridium difficile infection: a rare case report and brief review of the literature. J Gastrointestin Liver Dis 25, 235–8.
- 15Kuźma-Mroczkowska E, Pańczyk-Tomaszewska M, Szmigielska A, Szymanik-Grzelak H, Roszkowska-Blaim M (2015) Mycoplasma pneumoniae as a trigger for Henoch-Schönlein purpura in children. Cent Eur J Immunol 40, 489–92.
- 16Parrey AH, Sofi F, Ahmad M, Kuchay A (2016) Aerococcus viridans infection presenting as cutaneous vasculitis in an immunocompetent patient. Reumatologia 54, 318–20.
- 17Bunker DR, Sullivan T (2016) A case of leukocytoclastic vasculitis caused by Listeria monocytogenes bacteremia. Case Rep Infect Dis article ID 1093453, 1–3.
- 18Moreno Martínez MJ, Palma Sánchez D, Peñas Martínez E, Haro Martínez A, Mayor González M (2017) Leukocytoclastic vasculitis and infection: report of a case. Reumatol Clin 13, 297–8.
- 19Kayria M, Chris O, Dhasmana DJ et al. (2017) Burkholderia cepacia complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case series. JRSM Open 8 (4), 1–4.
10.1177/2054270417692732 Google Scholar
- 20Heggtveit AH (1965) Syphilitic aortitis: autopsy experience at the Ottawa General Hospital since 1950. Can Med Assoc J 92, 880–1.
- 21Ramirez FD, Jamison BM, Hibbert B (2016) Infectious aortitis: a case-based review of diagnostic clues and consequences. Int Heart J 57, 645–8.
- 22Gornik HL, Creager M (2008) Aortitis. Circulation 117, 3039–51.
- 23Long R, Guzman R, Greenberg H, Safneck J, Hershfield E (1999) Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience. Chest 115, 522–31.
- 24Shariff N, Roberts J, Ahmed S (2009) Cutaneous vasculitis rash due to bacterial endocarditis. Heart 95 (2), 106.
- 25Salahuddin H, Luni FK, Siddiqui N, Rohs M, Kaw D, Altorok N (2015) Bacterial endocarditis complicated by leukocytoclastic vasculitis. Am J Med Sci 350, 500.
- 26Ha SE, Ban TH, Jung SM et al. (2015) Henoch-Schönlein purpura secondary to infective endocarditis in a patient with pulmonary valve stenosis and a ventricular septal defect. Korean J Intern Med 30, 406–10.
- 27Thongprayoon C, Cheungpasitporn W, Srivali N, Ungprasert P (2015) Coexistence of Henoch-Schönlein purpura and infective endocarditis in elderly. Am J Med 128, e17.
- 28Berquist JB, Bartels CM (2011) Rare association of Henoch-Schönlein purpura with recurrent endocarditis. WMJ 110, 38–40.
- 29Peñafiel-Sam J, Alarcón-Guevara S, Chang-Cabanillas S, Perez-Medina W, Mendo-Urbina F, Ordaya-Espinoza E (2017) Infective endocarditis due to Bartonella bacilliformis associated with systemic vasculitis: a case report. Rev Soc Bras Med Trop 50, 706–8.
- 30Veerappan I, Prabitha EN, Abraham A, Theodore S, Abraham G (2012) Double ANCA-positive vasculitis in a patient with infective endocarditis. Indian J Nephrol 22, 469–72.
- 31Wang KY, Shimajiri S, Yoshida T, Yamada S, Sasaguri Y (2010) An autopsy case of microscopic polyangiitis associated with bacterial endocarditis. J UOEH 32, 273–9.
- 32Abraham R, Irwin RB, Kannappan D, Isalska B, Koroma M, Younis N (2012) Cerebral vasculitis and Cardiobacterium valvarum endocarditis. J Med Microbiol 61, 1625–30.
- 33Walker DH, Mattern WD (1980) Rickettsial vasculitis. Am Heart J 100, 896–906.
- 34Pagnoux C, Cohen P, Guillevin L (2006) Vasculitides secondary to infections. Clin Exp Rheumatol 24, S71–81.
- 35Cervi A, Kelly D, Alexopoulou I, Khalidi N (2017) ANCA-associated pauci-immune glomerulonephritis in a patient with bacterial endocarditis: a challenging clinical dilemma. Clin Nephrol Case Stud 5, 32–7.
- 36Konstantinov KN, Harris AA, Hartshorne MF, Tzamaloukas AH (2012) Symptomatic anti-neutrophil cytoplasmic antibody-positive disease complicating subacute bacterial endocarditis: to treat or not to treat? Case Rep Nephrol Urol 2, 25–32.
- 37Rhee RL, Grayson PC, Merkel PA, Tomasson G (2017) Infections and the risk of incident giant cell arteritis: a population-based, case–control study. Ann Rheum Dis 76, 1031–5.
- 38England BR, Mikuls TR, Xie F, Yang S, Chen L, Curtis JR (2017) Herpes zoster as a risk factor for incident giant cell arteritis. Arthritis Rheumatol 69, 2351–8.
- 39Pender MP (2003) Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 24, 584–8.
- 40Saadoun D, Rosenzwajg M, Joly F et al. (2011) Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 365, 2067–77.
- 41Park KJ, Choi SH, Choi DH et al. (2003) Hepatitis C virus NS5A protein modulates c-jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2. J Biol Chem 278, 30711–8.
- 42Rieu V, Cohen P, André MH et al. (2002) Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxford) 41, 290–300.
- 43Montilla P, Dronda F, Moreno S, Ezpeleta C, Bellas C, Buzon L (1987) Lymphomatoid granulomatosis and the acquired immunodeficiency syndrome. Ann Intern Med 106, 166–7.
- 44Asano S, Mizuno S, Okachi S et al. (2016) Antineutrophil cytoplasmic antibody-associated vasculitis superimposed on infection-related glomerulonephritis secondary to pulmonary mycobacterium avium complex infection. Intern Med 55, 2439–45.
- 45Balakrishnan N, Ericson M, Maggi M, Breitschwerdt EB (2016) Vasculitis, cerebral infarction and persistent Bartonella henselae infection in a child. Parasit Vectors 9, 254–9.
- 46Guillevin L, Mahr A, Cohen P et al. (2004) Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 51, 482–7.
- 47Samson M, Puechal X, Devilliers H et al. (2014) Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors. Autoimmun Rev 13, 197–205.
- 48 AASLD/IDSA HCV Guidance Panel (2015) Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 62, 932–54.
- 49Cacoub P, Vautier M, Desbois AC, Lafuma A, Saadoun D (2017) Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: from interferon-based to direct-acting antivirals era. Liver Int 37, 1805–13.